Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.41 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.38 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1453272 | 0.81 | CA4 (0.48) | LMNAMTNR1AMTNR1BCHRNB4CHRNA3 | |
| SCHEMBL19725374 | 0.81 | LMNA (0.59) | LMNAMTNR1AMTNR1BCHRNB2CHRNA7 | |
| SCHEMBL19725372 | 0.81 | TRPA1 (0.48) | LMNAMTNR1AMTNR1BTRPA1KDM4E | |
| SCHEMBL19223071 | 0.79 | TRPA1 (0.48) | LMNAMTNR1AMTNR1BMAPTTRPA1 | |
| SCHEMBL19725376 | 0.79 | LMNA (0.42) | LMNAMTNR1AMTNR1BMAPTKDM4E | |
| SCHEMBL19997571 | 0.77 | OGG1 (0.49) | MAPTKDM4ESLC6A4ALDH1A1 | |
| SCHEMBL257324 | 0.77 | MTNR1A (0.52) | LMNAMTNR1AMTNR1BMAPTKDM4E | |
| SCHEMBL12550266 | 0.77 | MTNR1A (0.52) | LMNAMTNR1AMTNR1BMAPTKDM4E | |
| SCHEMBL28121089 | 0.77 | MTNR1A (0.52) | LMNAMTNR1AMTNR1BMAPTKDM4E | |
| SCHEMBL941113 | 0.77 | CA4 (0.43) | LMNAMTNR1AMTNR1BCHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110166029-A1 | Compositions And Methods For Diagnosing Autism Spectrum Disorders | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2011-07-07 | — | — | US | disclosed |
| US-20060216545-A1 | Electroluminescent polymer having 9-fluoren-2-yl-2,7-fluorenyl unit and electroluminescent device using same | SK CORPORATION (KR) | 2006-09-28 | — | — | US | disclosed |
| WO-2006101313-A1 | ELECTROLUMINESCENT POLYMER HAVING 9-FLUOREN-2-YL-2,7-FLUORENYL UNITS AND THE ELECTROLUMINESCENT DEVICE PREPARED USING THE SAME | SK CORPORATION (KR) | 2006-09-28 | — | — | WO | disclosed |
| WO-2006062323-A1 | ELECTROLUMINESCENT POLYMER HAVING 9-FLUOREN-2-YL-9-ARYL-2,7-FLUORENYL UNIT AND ELECTROLUMINESCENT DEVICE MANUFACTURED USING THE SAME | SK CORPORATION (KR) | 2006-06-15 | — | — | WO | disclosed |
| US-20060121314-A1 | Electroluminescent polymer having 9-fluoren-2-yl-9-aryl-2,7-fluorenyl unit and electroluminescent device manufactured using the same | SK CORPORATION (KR) | 2006-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166029-A1 | Compositions And Methods For Diagnosing Autism Spectrum Disorders | INA, MECP2, ADCYAP1R1 | LMNA 1202/4885MTNR1A 897/4885MTNR1B 1158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.